P2X7R deficiency alleviates cardiac senescence by enhancing mitophagy via the HuR/TRIM26/NR4A1 axis

Yixin Zhou1, Xin Zhong1,2, Zhijie Mao1

  • 1Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, The Key Laboratory of Cardiovascular Disease of Wenzhou, Wenzhou, China.

PubMed
Abstract

Insights

The purinergic 2×7 receptor (P2X7R) accelerates cardiac ageing by promoting the HuR/TRIM26/NR4A1 pathway, leading to impaired mitophagy. Inhibiting P2X7R may offer therapeutic benefits for age-related heart dysfunction.

Area of Science:

  • Cardiovascular Biology
  • Aging Research
  • Molecular Mechanisms of Disease

Background:

  • Cardiac ageing involves complex pathophysiological alterations with incompletely understood mechanisms.
  • The purinergic 2×7 receptor (P2X7R) is implicated in cardiovascular diseases, but its role in cardiac ageing is unclear.

Purpose of the Study:

  • To investigate the function of P2X7R in the process of cardiac ageing.
  • To elucidate the molecular pathways regulated by P2X7R in senescent hearts.

Main Methods:

  • Utilized P2X7R knockout mice and a D-galactose-induced ageing model.
  • Employed cardiac-specific overexpression of P2X7R and NR4A1 using AAV9.
  • Evaluated cardiac function, histopathology, and performed transcriptome sequencing.

Main Results:

  • P2X7R expression and serum levels increase with age and cardiac senescence.
  • P2X7R deficiency improved cardiac function and mitophagy in aged mice.
  • P2X7R overexpression exacerbated age-related cardiac dysfunction and mitophagy impairment.
  • Identified the HuR/TRIM26/NR4A1 axis as a key P2X7R-regulated pathway impacting mitophagy.

Conclusions:

  • P2X7R plays a critical role in accelerating cardiac ageing.
  • The HuR/TRIM26/NR4A1 signaling axis is a key mediator of P2X7R's effects on cardiac senescence.
  • Targeting P2X7R may be a therapeutic strategy for age-related cardiac dysfunction.